Tuesday, 17 November 2026European Markets

MITHRA Stock Bullish Momentum With A 14% Jump So Far On Wednesday

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - Shares of MITHRA (BEL 20: MITRA.BR) rose by a staggering 14.56% to €3.54 at 13:24 EST on Wednesday, after two consecutive sessions in a row of gains. BEL 20 is falling 0.45% to €3,834.84, after two sequential sessions in a row of losses. This seems, as yet, a somewhat bearish trend exchanging session today.

MITHRA's last close was €3.09, 81.14% below its 52-week high of €16.38.

About MITHRA

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a solution for treating menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it offers NEXTSTELLIS, an oral contraceptive pill. In addition, the company provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Liège, Belgium.

Earnings Per Share

As for profitability, MITHRA has a trailing twelve months EPS of €-2.25.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -138.93%.

More news about MITHRA (MITRA.BR).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

  1. Published before we listed source documents with each article.
  2. Published 8 Mar 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›